Purchases and Sales Made in Q4 2024 in Cytom X Therapeutics, Inc. (CTMX)
This table provides information about the institutional ownership of Cytom X Therapeutics, Inc. (CTMX) during Q4 2024. The information is specifically focused on institutions that hold shares of CytomX Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 17, 2025
Q4 2024
|
Traphagen Investment Advisors LLC
Oradell, NJ |
BUY
|
- |
30.5KNew |
$26.2K - $39.3K
|
30.5K
$25.6K
|
|
|
Jan 14, 2025
Q4 2024
|
Congress Park Capital LLC
|
SELL
|
- |
-251K- 20.68% |
$216K - $324K
|
965K
$810K
|
|
|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-1.04M- 63.52% |
$898K - $1.35M
|
600K
$504K
|